Cencora Income After Taxes 2010-2024 | COR
Cencora annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Cencora income after taxes for the quarter ending September 30, 2024 was $0.007B, a 97.86% decline year-over-year.
- Cencora income after taxes for the twelve months ending September 30, 2024 was $1.519B, a 12.31% decline year-over-year.
- Cencora annual income after taxes for 2024 was $1.519B, a 12.31% decline from 2023.
- Cencora annual income after taxes for 2023 was $1.733B, a 3.96% increase from 2022.
- Cencora annual income after taxes for 2022 was $1.667B, a 7.89% increase from 2021.
| Cencora Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $1,519 |
| 2023 | $1,733 |
| 2022 | $1,667 |
| 2021 | $1,545 |
| 2020 | $-3,400 |
| 2019 | $854 |
| 2018 | $1,616 |
| 2017 | $364 |
| 2016 | $1,428 |
| 2015 | $-138 |
| 2014 | $282 |
| 2013 | $493 |
| 2012 | $761 |
| 2011 | $697 |
| 2010 | $630 |
| 2009 | $512 |
| Cencora Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-09-30 | $7 |
| 2024-06-30 | $488 |
| 2024-03-31 | $421 |
| 2023-12-31 | $603 |
| 2023-09-30 | $349 |
| 2023-06-30 | $479 |
| 2023-03-31 | $428 |
| 2022-12-31 | $476 |
| 2022-09-30 | $299 |
| 2022-06-30 | $363 |
| 2022-03-31 | $555 |
| 2021-12-31 | $449 |
| 2021-09-30 | $436 |
| 2021-06-30 | $295 |
| 2021-03-31 | $434 |
| 2020-12-31 | $379 |
| 2020-09-30 | $-4,845 |
| 2020-06-30 | $287 |
| 2020-03-31 | $971 |
| 2019-12-31 | $187 |
| 2019-09-30 | $132 |
| 2019-06-30 | $302 |
| 2019-03-31 | $28 |
| 2018-12-31 | $392 |
| 2018-09-30 | $194 |
| 2018-06-30 | $278 |
| 2018-03-31 | $282 |
| 2017-12-31 | $862 |
| 2017-09-30 | $-345 |
| 2017-06-30 | $50 |
| 2017-03-31 | $411 |
| 2016-12-31 | $247 |
| 2016-09-30 | $146 |
| 2016-06-30 | $349 |
| 2016-03-31 | $603 |
| 2015-12-31 | $330 |
| 2015-09-30 | $361 |
| 2015-06-30 | $214 |
| 2015-03-31 | $-513 |
| 2014-12-31 | $-200 |
| 2014-09-30 | $66 |
| 2014-06-30 | $-13 |
| 2014-03-31 | $180 |
| 2013-12-31 | $49 |
| 2013-09-30 | $51 |
| 2013-06-30 | $64 |
| 2013-03-31 | $204 |
| 2012-12-31 | $175 |
| 2012-09-30 | $192 |
| 2012-06-30 | $190 |
| 2012-03-31 | $219 |
| 2011-12-31 | $160 |
| 2011-09-30 | $138 |
| 2011-06-30 | $184 |
| 2011-03-31 | $214 |
| 2010-12-31 | $161 |
| 2010-09-30 | $134 |
| 2010-06-30 | $163 |
| 2010-03-31 | $181 |
| 2009-12-31 | $151 |
| 2009-09-30 | $130 |
| 2009-06-30 | $125 |
| 2009-03-31 | $144 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $45.651B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $88.397B | 10.97 |
| Natera (NTRA) | United States | $23.104B | 0.00 |
| DiDi Global (DIDIY) | China | $21.969B | 0.00 |
| ICON (ICLR) | Ireland | $18.002B | 16.03 |
| Avantor (AVTR) | United States | $14.742B | 22.10 |
| Viatris (VTRS) | United States | $13.929B | 4.29 |
| Revvity (RVTY) | United States | $13.859B | 24.08 |
| BioMerieux (BMXMF) | France | $12.558B | 0.00 |
| CochLear (CHEOY) | Australia | $12.074B | 0.00 |
| Solventum (SOLV) | United States | $11.587B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.906B | 30.72 |
| Doximity (DOCS) | United States | $9.727B | 57.25 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.707B | 0.00 |
| Charles River Laboratories (CRL) | United States | $9.517B | 18.39 |
| HealthEquity (HQY) | United States | $8.694B | 43.62 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.259B | 29.11 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Organon (OGN) | United States | $4.082B | 4.12 |
| Sotera Health (SHC) | United States | $3.713B | 19.86 |
| BrightSpring Health Services (BTSG) | United States | $2.990B | 63.59 |
| Surgery Partners (SGRY) | United States | $2.625B | 29.93 |
| Concentras Parent (CON) | United States | $2.513B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.455B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.277B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.255B | 0.00 |
| Premier (PINC) | United States | $2.006B | 10.44 |
| PACS (PACS) | United States | $1.955B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.734B | 45.50 |
| Teladoc Health (TDOC) | United States | $1.699B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.658B | 0.00 |
| Progyny (PGNY) | United States | $1.597B | 32.34 |
| Establishment Labs Holdings (ESTA) | $1.282B | 0.00 | |
| CareDx (CDNA) | United States | $1.267B | 0.00 |
| Embecta (EMBC) | United States | $1.132B | 7.92 |
| Pediatrix Medical (MD) | United States | $1.068B | 10.45 |
| AMN Healthcare Services Inc (AMN) | United States | $1.023B | 6.93 |
| Agilon Health (AGL) | United States | $1.001B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.563B | 14.73 |
| SBC Medicals (SBC) | United States | $0.526B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.490B | 0.00 |
| DocGo (DCGO) | United States | $0.416B | 15.69 |
| Sonida Senior Living (SNDA) | United States | $0.409B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.242B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.234B | 0.00 |
| MultiPlan (MPLN) | United States | $0.206B | 0.00 |
| LifeMD (LFMD) | United States | $0.205B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.197B | 0.00 |
| Beauty Health (SKIN) | United States | $0.192B | 0.00 |
| Biodesix (BDSX) | United States | $0.185B | 0.00 |
| Nutex Health (NUTX) | United States | $0.168B | 0.00 |
| So-Young (SY) | China | $0.104B | 17.70 |
| ModivCare (MODV) | United States | $0.094B | 5.09 |
| Ascend Wellness Holdings (AAWH) | United States | $0.092B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.026B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |